Pharmacologic therapies in patients with exacerbation of chronic obstructive pulmonary disease: a systematic review with meta-analysis
Background: Chronic obstructive pulmonary disease (COPD) is characterized by frequent
exacerbations. Purpose: To evaluate the comparative effectiveness and adverse events …
exacerbations. Purpose: To evaluate the comparative effectiveness and adverse events …
Pharmacologic therapies in patients with exacerbation of chronic obstructive pulmonary disease: A systematic review with meta-analysis
CC Dobler, AS Morrow… - Annals of internal …, 2020 - mayoclinic.pure.elsevier.com
Background: Chronic obstructive pulmonary disease (COPD) is characterized by frequent
exacerbations. Purpose: To evaluate the comparative effectiveness and adverse events …
exacerbations. Purpose: To evaluate the comparative effectiveness and adverse events …
[PDF][PDF] Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease
CC Dobler, AS Morrow… - Annals of Internal …, 2020 - unmfm.pbworks.com
Background: Chronic obstructive pulmonary disease (COPD) is characterized by frequent
exacerbations. Purpose: To evaluate the comparative effectiveness and adverse events …
exacerbations. Purpose: To evaluate the comparative effectiveness and adverse events …
Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis
C Dobler, AS Morrow, B Beuschel… - Annals of internal …, 2020 - dora.health.qld.gov.au
Chronic obstructive pulmonary disease (COPD) is characterized by frequent exacerbations.
To evaluate the comparative effectiveness and adverse events (AEs) of pharmacologic …
To evaluate the comparative effectiveness and adverse events (AEs) of pharmacologic …
Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis.
CC Dobler, AS Morrow, B Beuschel… - Annals of Internal …, 2020 - europepmc.org
Background: Chronic obstructive pulmonary disease (COPD) is characterized by frequent
exacerbations. Purpose: To evaluate the comparative effectiveness and adverse events …
exacerbations. Purpose: To evaluate the comparative effectiveness and adverse events …
Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis
CC Dobler, AS Morrow, B Beuschel… - Annals of Internal …, 2020 - research.bond.edu.au
Purpose: To evaluate the comparative effectiveness and adverse events (AEs) of
pharmacologic interventions for adults with exacerbation of COPD. Data Sources: English …
pharmacologic interventions for adults with exacerbation of COPD. Data Sources: English …
Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis
CC Dobler, AS Morrow, B Beuschel… - Annals of internal …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Chronic obstructive pulmonary disease (COPD) is characterized by frequent
exacerbations. Purpose To evaluate the comparative effectiveness and adverse events …
exacerbations. Purpose To evaluate the comparative effectiveness and adverse events …
Pharmacologic therapies in patients with exacerbation of chronic obstructive pulmonary disease: A systematic review with meta-analysis
CC Dobler, AS Morrow, B Beuschel… - Annals of internal …, 2020 - mayoclinic.elsevierpure.com
Background: Chronic obstructive pulmonary disease (COPD) is characterized by frequent
exacerbations. Purpose: To evaluate the comparative effectiveness and adverse events …
exacerbations. Purpose: To evaluate the comparative effectiveness and adverse events …
Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis
C Dobler, AS Morrow… - Annals of …, 2020 - qldresearch.intersearch.com.au
Chronic obstructive pulmonary disease (COPD) is characterized by frequent exacerbations.
To evaluate the comparative effectiveness and adverse events (AEs) of pharmacologic …
To evaluate the comparative effectiveness and adverse events (AEs) of pharmacologic …